Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective.

MLA

Oh, Mok, et al. “Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective.” Critical Care Medicine, vol. 48, no. 10, Oct. 2020, pp. e906–11. EBSCOhost, https://doi.org/10.1097/CCM.0000000000004501.

APA

Oh, M., Patanwala, A. E., Alkhatib, N., Almutairi, A., Abraham, I., & Erstad, B. (2020). Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective. Critical Care Medicine, 48(10), e906–e911. https://doi.org/10.1097/CCM.0000000000004501

Chicago

Oh, Mok, Asad E. Patanwala, Nimer Alkhatib, Abdulaali Almutairi, Ivo Abraham, and Brian Erstad. 2020. “Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective.” Critical Care Medicine 48 (10): e906–11. doi:10.1097/CCM.0000000000004501.